Artimplant presents the three months interim report 2008 at the AGM on May 6, 05:00 PM (GMT+1)

Artimplant presents the three months interim report 2008 at the AGM on May 6,
05:00 PM (GMT+1)

Västra Frölunda, Sweden, April 30, 2008 
CEO Hans Rosén and CFO Lars-Johan Cederbrant present the three months interim
report 2008 at the AGM on May 6, 05:00 PM (GMT+1).

The presentation will be in Swedish. After the AGM the presentation will be
published at the website of the Company. No conference call will be held
regarding this interim report. 

Please note that Artimplant's three months interim report 2008 will be
distributed with a press release on May 6, 2008, approximately 04:00 PM Central
European Time (GMT+1). 



For further information, please contact:
Hans Rosén, CEO, phone +46 (0)31-746 56 00, +46 (0)708 58 34 70,
hans.rosen@artimplant.com

Lars-Johan Cederbrant, CFO, phone +46 (0)31-746 56 54, +46 (0)703 01 68 54,
lars-johan.cederbrant@artimplant.com

Further information at www.artimplant.com where one also can subscribe to future
press releases;
www.artimplant.com/investors-media/subscribe-to-press-releases.html

About Artimplant
Artimplant is a biomaterials company focused on solutions to problems in
orthopedic and oral surgery. We restore health through the development,
production, and marketing of degradable implants that regenerate body functions
and improve quality of life. Our products, made from Artelon®, meet unmet
clinical needs and are marketed in a growing number of therapy areas. Artimplant
produces implants for treatment of osteoarthritis in hands and feet, for
shoulder and other soft tissue injuries as well as oral applications.

Artimplant is a public company listed on the OMX Nordic Exchange Stockholm in
the Small Cap segment and in the healthcare sector.

Forward-looking statements
This press release contains forward-looking statements as defined in the U.S.
Private Securities Litigation Reform Act of 1995. Readers are cautioned not to
place undue reliance on these forward-looking statements. Actual results may
differ materially from those indicated by these forward-looking statements as a
result of risks and uncertainties impacting the Company's business including
increased competition; the ability of the Company to expand its operations and
to attract and retain qualified professionals; technological obsolescence;
general economic conditions; and other risks detailed from time to time in the
Company's filings.